A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy Adults

NCT01160172 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Staphylococcal

Interventions

BIOLOGICAL: Staphylococcal investigational vaccine GSK2392103A
BIOLOGICAL: Staphylococcal investigational vaccine GSK2392105A
BIOLOGICAL: Staphylococcal investigational vaccine GSK2392106A
BIOLOGICAL: Staphylococcal investigational vaccine GSK2392019A
DRUG: Saline placebo

Sponsor

GlaxoSmithKline